These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer]. Loman N Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304 [TBL] [Abstract][Full Text] [Related]
7. Genetic testing for BRCA1 and BRCA2 genes. Kessenich CR; Bacher K; Moore PA Nurse Pract; 2014 Jun; 39(6):8-10. PubMed ID: 24841458 [No Abstract] [Full Text] [Related]
8. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 24366402 [No Abstract] [Full Text] [Related]
10. Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations. Silva E; Lynch H Breast J; 2006; 12(3):280-1; author reply 282-4. PubMed ID: 16684334 [No Abstract] [Full Text] [Related]
11. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254 [TBL] [Abstract][Full Text] [Related]
12. Genetics of breast cancer: contribution of BRCA1/2 genes alterations to hereditary predisposition. Branković-Magić M; Dobricić J; Krivokuća A Vojnosanit Pregl; 2012 Aug; 69(8):700-6. PubMed ID: 22924267 [No Abstract] [Full Text] [Related]
13. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 25006622 [No Abstract] [Full Text] [Related]
14. Hereditary breast cancer and genetic counseling in young women. Brunet J Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():7-9. PubMed ID: 20711663 [No Abstract] [Full Text] [Related]
15. Breast cancer risk assessment and genetic testing: complexities, conundrums, and community. Peshkin BN Breast Dis; 2006-2007; 27():1-3. PubMed ID: 17917137 [No Abstract] [Full Text] [Related]
16. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857 [TBL] [Abstract][Full Text] [Related]
17. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Forman AD; Hall MJ Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331 [TBL] [Abstract][Full Text] [Related]
18. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Moyer VA; Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376 [TBL] [Abstract][Full Text] [Related]
19. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer. Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591 [TBL] [Abstract][Full Text] [Related]